Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSND.L Regulatory News (SND)

  • There is currently no data for SND

Exercise of Options

26 Mar 2015 07:00

RNS Number : 4995I
Sanderson Group PLC
26 March 2015
 



FOR IMMEDIATE RELEASE 26 MARCH 2015

 

SANDERSON GROUP PLC

 

Exercise of Options

Sanderson Group plc ('Sanderson' or 'the Group'), the software and IT services business specialising in multi-channel retail and manufacturing markets in the UK and Ireland, announces that Adrian Frost has exercised options over 34,000 ordinary shares under the Group's EMI scheme at an exercise price of 57 pence per ordinary share. It is also announced that Adrian Frost has sold 30,000 ordinary shares at a price of 67 pence per ordinary share. Following the exercise of these options and sale of shares, Adrian Frost is interested in 247,421 ordinary shares representing 0.45% of the issued share capital of the Group.

Sanderson also announces that an employee has exercised options over 90,000 ordinary shares under the Group's CSOP Scheme. 50,000 ordinary shares are to be issued at a price of 27.5 pence per ordinary share and a further 40,000 ordinary shares will be issued at a price of 30.0 pence per ordinary share. Application has been made for the 124,000 new shares (the New Ordinary Shares) to be admitted to AIM. Admission of 90,000 shares is expected to take place on 30 March 2015 and for the remaining 34,000 shares the admission date is expected to be 31 March 2015.

The New Ordinary Shares issued pursuant to the exercise of options will rank pari passu with the existing Sanderson ordinary shares. Following allotment of the New Ordinary Shares, Sanderson will have in issue 54,548,133 ordinary shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of Sanderson, under the Disclosure and Transparency Rules.

 

 

Sanderson Group plc 0333 123 1400

Christopher Winn, Chairman

Adrian Frost, Finance Director

Ian Newcombe, Director

 

Charles Stanley Securities 020 7149 6000

Nominated Advisor

Mark Taylor

 

Winningtons Financial 0117 985 8989

Paul Vann or 07768 807631

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEPGUGGWUPAUUQ
Date   Source Headline
21st Aug 20247:00 amRNSCancellation - Sondrel (Holdings) plc
12th Aug 20241:54 pmRNSResult of GM, Cancellation and Re-registration
22nd Jul 20247:00 amRNSProposed cancellation of Admission, Notice of GM
18th Jul 20248:09 amRNSFinal Results and Posting of Annual Report-Replace
18th Jul 20247:30 amRNSRestoration - Sondrel (Holdings) plc
18th Jul 20247:01 amRNSChief Financial Officer Succession
18th Jul 20247:00 amRNSFinal Results and Posting of Annual Report
16th Jul 20247:00 amRNSNotice of Results
1st Jul 20247:30 amRNSSuspension - Sondrel (Holdings) plc
27th Jun 20245:32 pmRNSResult of AGM
24th Jun 20244:26 pmRNSSuspension of Trading on AIM
18th Jun 20247:00 amRNSDirectorate Changes
12th Jun 202412:45 pmRNSUpdate re Subscription and Loan Conversion
10th Jun 202410:40 amRNSReceipt of NSIA Approval
30th May 20241:52 pmRNSResult of General Meeting
29th May 20246:07 pmRNSNotice of AGM
29th May 20247:00 amRNSRegulatory Condition to Conditional Subscription
22nd May 20247:00 amRNSChief Executive Officer Succession
14th May 20247:00 amRNSSubscription and Posting of Circular
29th Apr 20242:35 pmRNSPDMR Dealing
29th Apr 20247:00 amRNSSuccessful Milestone Completion
22nd Apr 20244:45 pmRNSPDMR Dealings
10th Apr 20245:26 pmRNSNotification of Major Holdings
2nd Apr 20249:39 amRNSNotification of Major Holdings
28th Mar 20241:08 pmRNSFurther CLN and Amended Exclusivity Agreement
27th Mar 20244:55 pmRNSUpdated Supply Arrangements
25th Mar 20243:46 pmRNSResult of General Meeting
25th Mar 20247:00 amRNSFurther re Material ASIC contract
11th Mar 20247:00 amRNSPosting of Circular and Notice of General Meeting
6th Mar 20247:00 amRNSConvertible Loan Note and Exclusivity Agreement
1st Mar 20247:00 amRNSFurther re Corporate Update
27th Feb 202412:52 pmRNSReplacement: Notification of Major Holdings
27th Feb 20248:33 amRNSNotification of Major Holdings
27th Feb 20247:00 amRNSNew Contract Win and Corporate Update
8th Feb 20248:42 amRNSStatement re Share Price Movement
5th Feb 20247:00 amRNSCorporate Update
10th Jan 20247:00 amRNSFY23 Update
5th Jan 20247:00 amRNSBoard Change
28th Dec 20232:52 pmRNSTrading Update
1st Dec 20233:31 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSResult of placing of shares in Sondrel (Holdings)
23rd Nov 20237:00 amRNSChange of Nominated Adviser and Broker
13th Nov 20237:00 amRNSProduction Order
20th Oct 20237:00 amRNSFounding member of Arm Total Design ecosystem
27th Sep 202312:01 pmRNSNotification of Major Holdings
27th Sep 202311:57 amRNSNotification of Major Holdings
21st Sep 20237:00 amRNSDelivery of prototypes for three ASIC projects
21st Sep 20237:00 amRNSResults for the half year ended 30 June 2023
20th Sep 20231:09 pmRNSBoard Update
18th Sep 20237:00 amRNSSenior Management Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.